Complex Infection-Control Measures with Disinfectant Switch Help the Successful Early Control of Carbapenem-Resistant Acinetobacter baumannii Outbreak in Intensive Care Unit
-
Published:2024-09-11
Issue:9
Volume:13
Page:869
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Kelemen Jozsef1, Sztermen Marton1, Dakos Eva Krisztina1, Budai Jozsef1, Katona Jozsef1, Szekeressy Zsuzsanna2, Sipos Laszlo1ORCID, Papp Zoltan1, Stercz Balazs34ORCID, Dunai Zsuzsanna A.4ORCID, Kocsis Bela3ORCID, Juhasz Janos35ORCID, Michelisz Fruzsina1, Daku Zsuzsanna1, Domokos Judit34ORCID, Szabo Dora134ORCID, Eross Lorand1ORCID
Affiliation:
1. Department of Neurosurgery and Neurointervention, Semmelweis University, 1083 Budapest, Hungary 2. Gyula Nyírő National Institute of Psychiatry and Addiction, 1135 Budapest, Hungary 3. Institute of Medical Microbiology, Semmelweis University, 1089 Budapest, Hungary 4. HUN-REN-SU Human Microbiota Research Group, 1052 Budapest, Hungary 5. Faculty of Information Technology and Bionics, Péter Pázmány Catholic University, 1083 Budapest, Hungary
Abstract
A carbapenem-resistant Acinetobacter baumannii (CRAB) outbreak in an intensive care unit (ICU) was contained by an improved infection-control measure that included a disinfectant policy. In our retrospective cohort study, we describe the epidemiological investigations and infection-control measures during this outbreak. Descriptive analysis was used to summarize patient demographics, neurological diseases, surgical treatment, underlying diseases, infection, and outcomes. In December 2023, two CARB-positive patients were observed in the ICU, and four more patients became CRAB-positive in January. During this outbreak, there was an overlap of hospitalization periods among the CRAB-positive patients, and CRAB was isolated from the environment; the isolated CRAB strain was identical. Infection-control measures, including hand hygiene, contact precautions and isolation, surveillance, decolonization, environmental cleaning, and disinfection, were reviewed and modified. The aim of this study was to examine the molecular background of the effectiveness of the disinfectant shift used during successful outbreak control. Experiments were carried out to study the phenotypic sensitivity and genetic background of different disinfectant agents. A thorough analysis of the detected CRAB strain included whole-genome sequencing (WGS), investigation of the qacE and qacEΔ1 genes’ relative expression by qPCR after exposure to different disinfectant solutions, as well as an analysis of biofilm formation. WGS analysis of the CRAB strain identified that an ST2 high-risk clone was responsible for the outbreak, which produced OXA-83 and ADC-30 beta-lactamases; in addition, qacE and qacEΔ1 genes were also detected, which confer resistance to disinfectants containing quaternary ammonium compounds (QACs). A qPCR analysis demonstrated that after exposure to different disinfectants, the gene expression levels of qacE and qacEΔ1 increased and correlated with concentrations of QACs of disinfectants. During the outbreak, the standard-of-care QAC-based disinfectant was changed to a mainly alcohol-based agent in the ICU, which contributed to the successful control of this outbreak, and no additional patients were identified with CRAB. We conclude that continuous surveillance and hand hygiene training combined with fast identification and reaction to new cases, as well as an in-depth analysis of multidrug-resistant outbreak strains and investigation of their disinfectant tolerance/resistance during an outbreak, are essential to effectively control the spread of nosocomial pathogens. The smart policy of disinfectant agent selection played a crucial role in controlling the outbreak and ensuring patient safety in the ICU.
Funder
HUN-REN-SU, the Human Microbiota Research Group European Union’s Horizon 2020 research and innovation program János Bolyai Scholarship
Reference60 articles.
1. An outbreak of multi-drug-resistant Acinetobacter baumannii on a burns ICU and its control with multi-faceted containment measures;Obenhuber;J. Hosp. Infect.,2024 2. Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales in Fiji: A multicentre prospective observational study;Baleivanualala;Lancet Reg. Health West Pac.,2024 3. Su, P.W., Yang, E.C., Moi, S.H., Yang, C.H., and Chuang, L.Y. (2023). Prevalence of Carbapenem Resistance Genes among Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan. Antibiotics, 12. 4. Tickler, I.A., Kawa, D., Obradovich, A.E., Fang, F.C., Tenover, F.C., and The Healthcare Associated Infections Consortium (2023). Characterization of Carbapenemase- and ESBL-Producing Gram-Negative Bacilli Isolated from Patients with Urinary Tract and Bloodstream Infections. Antibiotics, 12. 5. Seifert, H., Muller, C., Stefanik, D., Higgins, P.G., Wohlfarth, E., and Kresken, M. (2023). In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates. Antibiotics, 12.
|
|